A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

NCT02508389 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Radiation Induced Oral Mucositis

Interventions

DRUG: Low Dose GC4419: 30mg/day
DRUG: High Dose GC4419: 90mg/day
DRUG: Placebo
RADIATION: Intensity-Modulated Radiation Therapy
DRUG: Cisplatin

Sponsor

Galera Therapeutics, Inc.